Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphomaBrian T. Hill, Brad S. Kahl, Loretta J. Nastoupil et al.|British Journal of Haematology|2018Cited by 51
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain MetastasesAmi N. Shah, Massimo Cristofanilli, Jenny C. Chang et al.|Clinical Breast Cancer|2022Cited by 14
Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall SurvivalAllison Winter, Brian T. Hill, Loretta J. Nastoupil et al.|Blood|2018Cited by 10
Abstract P2-08-04: Progressive metastatic breast cancer with no detectable circulating tumor DNA: Evaluating limitations of this highly sensitive toolAmi N. Shah, Massimo Cristofanilli, Lorenzo Gerratana et al.|Cancer Research|2022Cited by 0